[{"id":"35ca491d-0cc1-434a-914b-6dc84cb52011","acronym":"","url":"https://clinicaltrials.gov/study/NCT05574608","created_at":"2022-10-10T14:05:46.075Z","updated_at":"2024-07-02T16:35:49.544Z","phase":"Phase 1","brief_title":"Allogenic CD123-CAR-NK Cells in the Treatment of Refractory/Relapsed Acute Myeloid Leukemia","source_id_and_acronym":"NCT05574608","lead_sponsor":"Affiliated Hospital to Academy of Military Medical Sciences","biomarkers":" CD123 • IL3RA","pipe":" | ","alterations":" CD123 positive","tags":["CD123 • IL3RA"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD123 positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e JD023"],"overall_status":"Recruiting","enrollment":" Enrollment 12","initiation":"Initiation: 10/01/2022","start_date":" 10/01/2022","primary_txt":" Primary completion: 10/30/2023","primary_completion_date":" 10/30/2023","study_txt":" Completion: 10/30/2024","study_completion_date":" 10/30/2024","last_update_posted":"2023-04-26"}]